Explore Stanford technologies available for licensing:

Researchers at Stanford have developed a method for identifying a subject that is at risk of progression to clinically significant COVID-19 infection or disease.

Researchers at Stanford and CZ Biohub San Francisco have developed a method capable of assaying a broad spectrum of coding and noncoding RNA from a single cell, thus enabling simultaneous analysis of protein-coding, long-noncoding, microRNA and other noncoding RNA transcripts

Researchers at the University of California Berkeley and Stanford have developed a bespoke, high throughput method for determining DNA-protein interactions in highly repetitive portions of the human genome.

The inventors discovered that a known small molecule tyrosine kinase inhibitor may correct the errant signaling pathways in the rare diseases Hereditary Hemorrhagic Telangiectasia (HHT) and Pulmonary Arterial Hypertension (PAH).

Stanford researchers have developed saponin lipid-based nanoparticles in which both toll-like receptor agonists (TLRas) and other potent molecular adjuvants can be encapsulated to improve vaccine potency, increase antibody titers, and induce more robust neutralizing antibody r

Researchers at Stanford have discovered long sought after light gated potassium selective channelrhodopsins., HcKCR1 and HcKCR2.

Stanford researchers have solved the Cryo-EM structure of a powerful new optogenetic actuator, ChRmine, and have successfully used structure guided design to create three new proteins: rsChRmine, hsChRmine and hs/rs ChRmine, conferring red-shifted, high-speed and a combination

Background: Researchers at Stanford have discovered a method to create lattice microneedle structures using high resolution continuous liquid interface printing (CLIP) technology.

Stanford inventors have developed an information theoretic, seizure detection algorithm for electroencephalography (EEG) towards improving diagnosis, management, and treatment of patients with epilepsy.

Despite their cytotoxic capacity, neutrophils are often co-opted by cancers to promote immunosuppression, tumor growth, and metastasis. Consequently, these cells have received little attention as potential cancer immunotherapeutic agents.

Researchers at Stanford University have discovered a new type of integrin-mediated cell adhesion, called curved adhesion, that represents the dominant structure in 3D physiological environments.

Stanford researchers have created a technology using CyTOF (Cytometry by Time Of Flight mass spectrometry) and CODEX (CO-Detection by indEXing) imaging to systematically analyze cell therapies produced ex vivo and their effects in vivo.

Flow batteries have an attractive battery architecture due to their scalability, long cycle-life, and power-to-energy tunability.

Researchers at Stanford have invented a novel hydrogel with enhanced retention and extended durability. This hydrogel can be held together three times longer than many alternatives without sacrificing its self-healing attributes during injection.

Researchers from Stanford University have developed an algorithm for electromagnetic device prototyping which optimizes geometric shape based on physical functionality.